Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipids and progressive kidney disease.

J F Moorhead1

  • 1Department of Nephrology, Royal Free Hospital, London, England, United Kingdom.

Kidney International. Supplement
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD36 and lipid metabolism in the evolution of atherosclerosis.

British medical bulletin·2018
Same author

The PPARalpha ligand fenofibrate: meeting multiple targets in diabetic nephropathy.

Kidney international·2006
Same author

Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10.

Tissue antigens·2004
Same author

Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors.

Biochemical Society transactions·2004
Same author

Dialysis induces cyclosporine a resistance: induction therapy with bolus ATG-Fresenius increases cyclosporine sensistivity.

Transplantation proceedings·2003
Same author

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation.

Kidney international·2001

Nephrotic syndrome involves high lipids, which may drive kidney disease progression. More research is needed on long-term lipid-lowering therapy for patients with proteinuria and progressive renal disease.

Area of Science:

  • Nephrology
  • Metabolic Disorders
  • Cardiovascular Science

Background:

  • Nephrotic syndrome is characterized by proteinuria, edema, and hyperlipidemia.
  • Hyperlipidemia, a key feature of nephrotic syndrome, is increasingly recognized for its potential role in progressive renal disease.
  • Experimental data highlight a link between hyperlipidemia and kidney disease progression in animal models.

Purpose of the Study:

  • To review the metabolic factors contributing to nephrotic syndrome pathology.
  • To explore the connection between glomerular disease and atherosclerosis.
  • To emphasize the need for studies on lipid-lowering therapy in progressive renal disease.

Main Methods:

  • Literature review focusing on metabolic aspects of nephrotic syndrome.

Related Experiment Videos

  • Analysis of experimental data from animal models.
  • Discussion of analogies between renal and vascular diseases.

    • Main Results:

    • Hyperlipidemia is a prominent clinical manifestation of nephrotic syndrome.
    • Experimental evidence suggests a role for hyperlipidemia in the progression of renal disease.
    • Analogies exist between glomerular disease and atherosclerosis.

    Conclusions:

    • Further investigation into the metabolic background of nephrotic syndrome is warranted.
    • Long-term studies of lipid-lowering therapy are crucial for patients with proteinuria and progressive renal disease.
    • A conceptual framework for understanding lipids in renal disease and potential therapies is discussed.